4.7 Editorial Material

Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome

Journal

ANNALS OF THE RHEUMATIC DISEASES
Volume 72, Issue 5, Pages 782-783

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/annrheumdis-2012-202754

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available